13
Current Trends In Research, Development And Production Of Prophylactic Vaccines: Report of Vaccipharma 2015 Congress
Authors: Acevedo R
Number of views: 538
Abstract
On June 14-19, 2015, the IUPHAR Section of Immunopharmacology
and the Cuban Society of Pharmacology, together with the LatinAmerican
Association of Pharmacology (ALF), Finlay Vaccine Institute
and other prestigious Cuban scientific institutions, organized the
Congress VACCIPHARMA 2015 (3rd International Congress on
Pharmacology of Vaccines), held as part of the First International
Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2015 (Meliá
Marina Varadero Hotel, in Varadero beach, Cuba)
VACCIPHARMA 2015 was organised into two large Workshops,
addressing topics related to the research, development, clinical
evaluation, production and quality control of Therapeutic and
Prophylactic Vaccines, respectively. At the same time the Workshop
on Prophylactic Vaccines was integrated by several Symposiums,
focused on meningococcal, pneumococcal, enteric, tuberculosis and
pertussis vaccines. About 250 delegates, including 100 international
researchers from 15 countries, attended this meeting.
The Congress had a remarkable Opening Session, with a Key
Lecture given by the outstanding scientist Professor Dr. Shiv Pillai
(United States of America), who talked about the changing views in
the field of the immunology of vaccination and the challenges ahead.
The aim of this review is to give an overview of the main topics
discussed in the Prophylactic Vaccines Workshop, not as a complete
narration of the events, but to provide an update of the latest state of
the art and methodologies being applied to prophylactic vaccines with
an expert commentary on the invited speakers.
Keywords: Vaccine; Neissseria meningitidi;, Mycobacterium
tuberculosis; Combined vaccines; Enteric Vaccines; Pneumococcal
Vaccines; Bordetella pertussis; Salmonella Typhi;